People with ANCA-associated vasculitis have about seven times the risk of developing an infection compared with individuals in the…
Articles by Iqra Mumal, MSc
ANCA-associated vasculitis does not increase healthcare resource utilization or in-hospital mortality rates in patients with Goodpasture’s syndrome, a study…
A low-dose glucocorticoid regimen, in which intravenous methylprednisolone (a type of steroid) is not routinely used, can be used to…
Patients with ANCA-associated vasculitis (AAV) treated with immunosuppressive agents have a higher risk of developing infectious complications, including pneumonia,…
Lesions in the lungs caused by ANCA-associated vasculitis (AAV) are variable among patients, but lung ultrasound appears to…
The complement system, an important part of immunity, is activated in ANCA-associated vasculitis patients with myeloperoxidase (MPO) antibodies as…
Treatment with Rituxan (rituximab) had some efficacy in eosinophilic granulomatosis with polyangiitis patients, leading to a reduction in…
Treatment using plasma exchange can help ANCA-associated vasculitis patients with severe renal damage become independent of dialysis in just…
The presence of blood in the urine is associated with a four times higher risk of kidney disease relapse…
Levels of Gremlin — a protein that is overexpressed during kidney damage — in the urine may serve as a…